News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
NIH Opposes Editing Human Embryos
Jef Akst | Apr 30, 2015
Following the publication of a study in which scientists used CRISPR to edit nonviable human embryos, the National Institutes of Health states it will not fund such research.
Picks: April 28, 2015
Tracy Vence | Apr 28, 2015
Embryo editing edition
Johns Hopkins Sued for Guatemala Experiments
Tracy Vence | Apr 2, 2015
The university is among defendants listed on a lawsuit filed this week by participants in controversial experiments conducted in Guatemala in the 1940s.
Call for Germline Editing Moratorium
Jef Akst | Mar 13, 2015
In response to speculation that groups have edited the DNA of human embryos, researchers request that gene editing of human reproductive cells be halted.
Journalists to Catalog Retractions
Kerry Grens | Dec 16, 2014
Staff of the blog Retraction Watch will create a database of papers retracted from the scientific literature.
John D. Loike | Dec 1, 2014
As new technologies emerge, we must choose our words for them with care: names can negatively bias the inevitable debates over the ethics of scientific advances.
Study: Scientists Witness Plagiarism Often
Kerry Grens | Nov 3, 2014
A meta-analysis of surveys used to gauge plagiarism among scientists finds that nearly one-third of researchers have witnessed the problem.
NIH Cleared of Tampering with Ethics Probe
Bob Grant | Sep 18, 2014
Government auditors absolve the National Institutes of Health of wrongdoing in the case of its involvement in an ethics investigation of a study involving premature babies.
Opinion: The Murky World of Medical Ethics
Nathalia Holt | Aug 7, 2014
Why are researchers still denying some study participants potentially life-saving therapies?
Bioethics of Experimental Ebola Treatments
Tracy Vence | Aug 7, 2014
The administration of an experimental serum to two American healthcare workers treated for Ebola on US soil raises questions of safety, efficacy, access, and ethics.